Top Markets
Coin of the day
Polomar Health Services, Inc. Polomar Health Services, Inc.

Polomar Health Services, Inc.

PMHS
Rang in Aktien #35424
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The... Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Aktienkurs
$0.14
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$3.93M
Veränderung (1 Tag)
-35.60%
Veränderung (1 Jahr)
-30.00%
Land
US
Handel Polomar Health Services, Inc. (PMHS)

Kategorie

Dividendenhistorie für Polomar Health Services, Inc. (PMHS)
Polomar Health Services, Inc. (Aktienkürzel: PMHS) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Polomar Health Services, Inc. (PMHS) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber